ライフサイエンスコーパス: transforming growth factor

1 In these cells, although transforming growth factor alpha (TGF-alpha) and epiderm

2 ADM in response to transforming growth factor alpha was also suppressed in

3 fibroblast growth factor 2, IL-7, IL-15, and transforming growth factor alpha) but lower levels of th

4 okines were increased, whereas the levels of transforming growth factor-alpha (TGF-alpha) and platele

5 ung disease induced by the overexpression of transforming growth factor-alpha (TGF-alpha), establishe

6 deleted fibroblasts had higher expression of transforming growth factor-alpha (Tgfa) mRNA and secrete

7 E-536) is a novel fusion protein that blocks transforming growth factor beta (TGF beta) superfamily i

8 induction of SP-A expression is repressed by transforming growth factor beta (TGF-beta) and by hypoxi

9 reatment there was a significant increase in transforming growth factor beta (TGF-beta) and concomita

10 Tumor-derived transforming growth factor beta (Tgf-beta) decreased Sat

11 EMT is induced by soluble transforming growth factor beta (TGF-beta) family member

12 To understand the cell-specific role of transforming growth factor beta (TGF-beta) in the myeloi

13 Transforming growth factor beta (TGF-beta) is an establi

14 Transforming growth factor beta (TGF-beta) isoforms are

15 Transforming growth factor beta (TGF-beta) pathways are

16 l as thymic stromal lymphopoietin (TSLP) and transforming growth factor beta (TGF-beta) plasma levels

17 We show that the type III transforming growth factor beta (TGF-beta) receptor (Tbe

18 ave previously determined that type I and II transforming growth factor beta (TGF-beta) receptors (Tb

19 in genes encoding various components of the transforming growth factor beta (TGF-beta) signaling cas

20 , which in turn activates the STAT3-mediated transforming growth factor beta (TGF-beta) signaling pat

21 plays a central role in the amplification of transforming growth factor beta (TGF-beta) signaling res

22 d pathways: NF-kappaB (p65) transactivation, transforming growth factor beta (TGF-beta) signaling, an

23 extracellular matrix, or decrease canonical transforming growth factor beta (TGF-beta) signaling.

24 xpression, a microRNA cluster that regulates transforming growth factor beta (TGF-beta) signaling.

25 been linked to NR4A1-dependent regulation of transforming growth factor beta (TGF-beta) signaling.

26 Kruppel-like factor 15 (Klf15), by both the transforming growth factor beta (TGF-beta) transcription

27 the prototypical prosclerotic growth factor, transforming growth factor beta (TGF-beta), is thought t

28 cules include collagen types I, III, and IV, transforming growth factor beta (TGF-beta), TGF-beta rec

29 Notably, expansion was mediated by transforming growth factor beta (TGF-beta)-containing ex

30 ShcA is an important mediator of ErbB2- and transforming growth factor beta (TGF-beta)-induced breas

31 Transforming growth factor beta (TGF-beta)-induced migra

32 er and serves as a common downstream node of transforming growth factor beta (TGFbeta) and bone morph

33 ber of key signaling pathways, including the transforming growth factor beta (TGFbeta) and epithelial

34 Transforming growth factor beta (TGFbeta) and fibroblast

35 Members of the transforming growth factor beta (TGFbeta) cytokine famil

36 e that low-dosage/short-duration exposure to transforming growth factor beta (TGFbeta) induces partia

37 Transforming growth factor beta (TGFbeta) is important i

38 Transforming growth factor beta (TGFbeta) is instrumenta

39 mong tumour-associated inflammatory factors, transforming growth factor beta (TGFbeta) is regarded as

40 Here we demonstrate that transforming growth factor beta (TGFbeta) is required fo

41 a family of signal transduction molecules in transforming growth factor beta (TGFbeta) ligand pathway

42 The transforming growth factor beta (TGFbeta) pathway plays

43 as TIEG1, plays essential roles in mediating transforming growth factor beta (TGFbeta) signaling and

44 Microarray studies identified impaired transforming growth factor beta (TGFbeta) signaling in c

45 In pausing-deficient embryos, the transforming growth factor beta (TGFbeta) signaling is e

46 dependent protein kinase (PDK1) and enhanced transforming growth factor beta (TGFbeta) signaling rath

47 d that these proteoglycans were dependent on transforming growth factor beta (TGFbeta) signaling.

48 2-HER3 signaling, or A83-01, an inhibitor of transforming growth factor beta (TGFbeta) signaling.

49 Transforming growth factor beta (TGFbeta) signalling is

50 Transforming growth factor beta (TGFbeta) signalling is

51 in (IL6) beta2SP(+/-) LSCs was activated by transforming growth factor beta (TGFbeta)-activated kina

52 SCs, both TANGO1 and the UPR were induced by transforming growth factor beta (TGFbeta).

53 hat significantly increased with exposure to transforming growth factor beta 1 (TGF-beta1), a potent

54 SMAD family member 2 (SMAD2), SMAD3, SMAD4, transforming growth factor beta 1 (TGFB1), TGFB2, TGFB3,

55 death-ligand 1, programmed cell death 1, or transforming growth factor beta 1 inhibitors.

56 e subclass expressed many genes regulated by transforming growth factor beta 1 that mediate immunosup

57 Plasmid transfection was used to modulate transforming growth factor beta 2 (TGF-beta2) gene expre

58 Connective tissue growth factor (CTGF) and transforming growth factor beta 3 (TGFbeta3) were then d

59 lated type 2 (IL-4 and IL-5) and regulatory (transforming growth factor beta [TGF-beta]) cytokines.

60 ding osteopontin, and LTBP4, encoding latent transforming growth factor beta [TGFbeta]-binding protei

61 yte-macrophage colony-stimulating factor and transforming growth factor beta alone, whereas CD14(+) c

62 However, transforming growth factor beta and bone morphogenetic p

63 To investigate the role of transforming growth factor beta and bone morphogenetic p

64 D206 and arginase-1) and secretory products (transforming growth factor beta and interleukin-6) and d

65 in-1, p21-activated kinase, microRNA 21, and transforming growth factor beta are also being explored

66 as attenuated by thrombin-induced release of transforming growth factor beta by platelets.

67 sition on CTCs through platelet secretion of transforming growth factor beta in response to CTC activ

68 ted immune-stimulatory cytokines and reduced transforming growth factor beta in the serum.

69 Treatment with transforming growth factor beta induced some cells to ad

70 The transforming growth factor beta isoforms, TGF-beta1, -be

71 Subsequent analysis suggested that anti-transforming growth factor beta neutralizing antibody, w

72 art by defective desmosomes and dysregulated transforming growth factor beta production and signaling

73 growth factor beta 1 (TGFB1), TGFB2, TGFB3, transforming growth factor beta receptor 1 (TGFBR1), and

74 bsence of CLCa was attributable to increased transforming growth factor beta receptor 2 (TGFbetaR2) s

75 Transforming growth factor beta receptor II interacting

76 lished a mechanism of negative regulation of transforming growth factor beta signaling mediated by th

77 iptional regulator SMAD6, which inhibits the transforming growth factor beta signaling pathway, is re

78 iptional regulator SMAD6, which inhibits the transforming growth factor beta signaling pathway, is re

79 Furthermore, we demonstrated that transforming growth factor beta stimulation resulted in

80 ced by a combination of ErbB2 activation and transforming growth factor beta stimulation, which is kn

81 (or GDF8) are closely related members of the transforming growth factor beta superfamily and are ofte

82 epiregulin (EREG), and other members of the transforming growth factor beta superfamily.

83 lowing isotropic chondrogenic induction with transforming growth factor beta to set up a dual-compart

84 Transforming growth factor beta treatment induced gene-b

85 Transforming growth factor beta type III receptor (Tbeta

86 cytokines (interleukin 6, 1beta, and 23 and transforming growth factor beta) restored CD4+ Th17 cell

87 local fibroblast activation by secretion of transforming growth factor beta, and a preneoplastic or

88 hogenetic protein, fibroblast growth factor, transforming growth factor beta, and Wnt signaling, and

89 h as proliferation-progenitor, proliferation-transforming growth factor beta, and Wnt-catenin beta1.

90 rences cannot be explained by a differential transforming growth factor beta, bone morphogenetic prot

91 that these HCV-infected hepatocytes express transforming growth factor beta, which activates stromal

92 Transforming growth factor beta-1 (TGF-beta1) induces FA

93 Transforming growth factor beta-1 (TGFbeta-1)-induced ph

94 V independently induce profibrogenic markers transforming growth factor beta-1 (TGFbeta1) (mediated b

95 Transforming growth factor beta-activated kinase 1 (TAK1

96 V-A6, and EV-D68 3C(pro) proteins all cleave transforming growth factor beta-activated kinase 1 (TAK1

97 Transforming growth factor beta-activated kinase 1 (TAK1

98 th death domain as an upstream regulator and transforming growth factor beta-activated kinase 1 as a

99 LZTFL1 inhibits transforming growth factor beta-activated mitogen-activa

100 CSF-1)-dependent donor macrophages, induce a transforming growth factor beta-high environment locally

101 during glucose starvation of HeLa cells and transforming growth factor beta-induced epithelial-to-me

102 scle (Asm) area with decreased periostin and transforming growth factor beta-positive cells within As

103 an CFC tissue, but surprisingly, more active transforming growth factor beta.

104 e activity of nuclear factor-kappaB, but not transforming growth factor beta.

105 -1beta; 2) IL-6; 3) IL-17A; 4) IL-23; and 5) transforming growth factor- beta.

106 e found to be an important source of cardiac transforming growth factor-beta (TGF-beta) and PAI-1 reg

107 the various regulatory factors tested, only transforming growth factor-beta (TGF-beta) demonstrated

108 ave markers that denote tissue residency and transforming growth factor-beta (TGF-beta) imprinting.

109 Furthermore, reduction of nephrin by transforming growth factor-beta (TGF-beta) in podocytes

110 The transforming growth factor-beta (TGF-beta) network of li

111 In the transforming growth factor-beta (Tgf-beta) pathway, expo

112 screen in human FA fibroblasts, we identify transforming growth factor-beta (TGF-beta) pathway-media

113 of both XPC and DDB1 through activating the transforming growth factor-beta (TGF-beta) pathway.

114 Transforming growth factor-beta (TGF-beta) plays an impo

115 nd that human PDACs with impaired epithelial transforming growth factor-beta (TGF-beta) signaling hav

116 The role of transforming growth factor-beta (TGF-beta) signaling in

117 Transforming growth factor-beta (TGF-beta) signaling is

118 The transforming growth factor-beta (TGF-beta) signaling pat

119 Hyperactivation of transforming growth factor-beta (TGF-beta) signaling pat

120 teins are central mediators in the canonical transforming growth factor-beta (TGF-beta) signaling pat

121 SIGNIFICANCE STATEMENT We show that reducing Transforming growth factor-beta (TGF-beta) signaling pro

122 Here, we show that transforming growth factor-beta (TGF-beta) signaling via

123 umulation, extracellular matrix degradation, transforming growth factor-beta (TGF-beta) signaling, co

124 clear-shuttling transcriptional mediators of transforming growth factor-beta (TGF-beta) signaling.

125 ere we show that epidermal Hedgehog (Hh) and Transforming growth factor-beta (TGF-beta) signalling me

126 eover, RNA-sequencing analysis shows altered transforming growth factor-beta (TGF-beta) signalling.

127 We have shown a vital role for transforming growth factor-beta (TGF-beta) signals in sa

128 Transforming growth factor-beta (TGF-beta) signals throu

129 o known as MIC-1, is a distant member of the transforming growth factor-beta (TGF-beta) superfamily a

130 lammatory drug-activated gene-1 (NAG-1) is a transforming growth factor-beta (TGF-beta) superfamily p

131 ABSTRACT: Transforming growth factor-beta (TGF-beta), RhoA/Rho-kin

132 Transforming growth factor-beta (TGF-beta), serine prote

133 f regulatory T cells (Treg cells) induced by transforming growth factor-beta (TGF-beta), we identifie

134 t analysis of gene expression changes during transforming growth factor-beta (TGF-beta)-induced EMT i

135 that the STAT3 signaling pathway attenuates transforming growth factor-beta (TGF-beta)-induced respo

136 injury produced by airway disease triggers a transforming growth factor-beta (TGF-beta)-mediated epig

137 Papillary thyroid carcinoma overexpress transforming growth factor-beta (TGF-beta).

138 and also required a novel intersection with transforming growth factor-beta (TGF-beta)/SMAD signalin

139 ced expression of Wnt target genes (axin-2), transforming growth factor-beta (TGF-beta1) and collagen

140 Activin, a member of the transforming growth factor-beta (TGFB) family, might be

141 d that DMF blocks the profibrotic effects of transforming growth factor-beta (TGFbeta) in SSc skin fi

142 integrin alphavbeta8-mediated activation of transforming growth factor-beta (TGFbeta).

143 Hepatic stellate cell (HSC) activation and transforming growth factor-beta 1 (TGF-beta1) expression

144 asuring fibrosis markers, proliferation, and transforming growth factor-beta 1 secretion.

145 le actin, fibronectin, collagen type 1a, and transforming growth factor-beta 1.

146 tine leads to release of fossilized factors (transforming growth factor-beta [TGF-beta] and bone morp

147 lation of IL-1 receptor-associated kinase 1, transforming growth factor-beta activated kinase-1, Ikap

148 expression, and profibrogenic cytokines (eg, transforming growth factor-beta and IL-13) and alteratio

149 vs E12.5, while abundance of elements of the transforming growth factor-beta and insulin-like growth

150 RDEB mice express high levels of transforming growth factor-beta and significantly lower

151 diac reprogramming was similarly enhanced on transforming growth factor-beta and WNT inhibition and w

152 Transforming growth factor-beta and WNT inhibitors joint

153 pilla inductive signaling pathways including transforming growth factor-beta and Wnt/beta-catenin.

154 Endoglin, a transforming growth factor-beta co-receptor, is highly e

155 Transforming growth factor-beta decreased RXFP1 in both

156 nished lung injury, collagen production, and transforming growth factor-beta expression and signaling

157 ial cell expansion, and collagen type IV and transforming growth factor-beta expression were signific

158 tensin-aldosterone system and members of the transforming growth factor-beta family play an important

159 the mature growth factor domains across the transforming growth factor-beta family.

160 hat further induction of Mmp-2 expression by transforming growth factor-beta I was blocked by Meg3 si

161 y both in the absence and in the presence of transforming growth factor-beta I.

162 We found that a combination of the transforming growth factor-beta inhibitor SB431542 and t

163 tion of cytotoxic T-lymphocyte antigen 4 and transforming growth factor-beta partially abrogated the

164 capacity to suppress multiple genes from the transforming growth factor-beta pathway and the producti

165 tracellular space, such as modulation of pro-transforming growth factor-beta processing, activation o

166 ted with reduced macrophage infiltration and transforming growth factor-beta production.

167 eceptor type 1C (ACVR1C), a component of the transforming growth factor-beta receptor superfamily.

168 own-regulation of thrombospondin 1, a latent transforming growth factor-beta receptor, and transcript

169 miR-337-3p requires Notch and transforming growth factor-beta signaling and exerts a b

170 We demonstrate that transforming growth factor-beta signaling confers this p

171 which was partly attributable to blockade of transforming growth factor-beta signaling in dermal fibr

172 ncreased expression of profibrotic genes and transforming growth factor-beta signaling in SFBLs.

173 was determined on mitochondrial function and transforming growth factor-beta signaling in vitro and i

174 ed genes were significantly enriched in the "transforming growth factor-beta signaling pathway".

175 agonists, likely through suppression of the transforming growth factor-beta signaling pathway.

176 mitochondrial ribosomal stress and increased transforming growth factor-beta signaling.

177 lation, suggesting that miR-542-5p increased transforming growth factor-beta signaling.

178 R-29 itself is regulated by SP1 activity and transforming growth factor-beta signaling.

179 nt role in kidney fibrogenesis by modulating transforming growth factor-beta signaling.

180 actor 11 (GDF11) and GDF8 are members of the transforming growth factor-beta superfamily sharing 89%

181 Endoglin (CD105), a receptor of the transforming growth factor-beta superfamily, has been re

182 molecular markers of fibrosis (collagen and transforming growth factor-beta) and immunostaining for

183 -2 complex had no effect on profibrotic (eg, transforming growth factor-beta) or type 17 immune respo

184 e because of myeloid deficiency of TGF-beta (transforming growth factor-beta) signaling.

185 ticularly robust when cells are treated with transforming growth factor-beta, an enhancer of EMT.

186 review, we summarize how the wingless (Wnt), transforming growth factor-beta, and bone morphogenetic

187 owed tumor necrosis factor-alpha, IFN-gamma, transforming growth factor-beta, and IL-13 as potential

188 mannose receptor-1 (CD206), interleukin-10, transforming growth factor-beta, arginase-1, matrix meta

189 that it involves collagen production through transforming growth factor-beta, at least in the case of

190 tifibrotic strategies include antagonists of transforming growth factor-beta, connective tissue growt

191 in kinases, tight junctions, focal adhesion, transforming growth factor-beta, vascular smooth muscle

192 Smad7 is a negative regulator of transforming growth factor-beta, which is increased in t

193 a/b and thereby modulating the expression of transforming growth factor-beta-activated kinase 1 (TAK1

194 GCD is caused by a point mutation in the transforming growth factor-beta-induced (TGFBI) gene, lo

195 Mechanistically, sphingosine ameliorates transforming growth factor-beta-induced collagen accumul

196 rmore, mimics of miR-185 and miR-186 blocked transforming growth factor-beta-induced collagen V overe

197 based selective miRNA analysis revealed that transforming growth factor-beta-induced enhanced express

198 ced collagen V overexpression and alleviated transforming growth factor-beta-induced epithelial-mesen

199 control fibroblasts and attenuated basal and transforming growth factor-beta-induced expression of CC

200 RNA-21 levels suppressed the IL10 effects on transforming growth factor-beta-induced fibrotic signali

201 evel, IL10 treatment significantly inhibited transforming growth factor-beta-induced transdifferentia

202 tase expression was significantly induced by transforming growth factor-beta.

203 ancer, mitogen-activated protein kinase, and transforming growth factor-beta.

204 secreted proreparative cytokines, including transforming growth factor-beta.

205 anonical Hh pathway, involving TGFbeta/SMAD (transforming growth factor-beta/Sma- and Mad-related fam

206 KEY POINTS: Transforming growth-factor-beta (TGF-beta) and RhoA/Rho-

207 of profibrotic gene markers, fibronectin and transforming-growth-factor-beta.

208 kophilin-2 (PKP2) in cardiomyocytes elevates transforming growth factor beta1 (TGF-beta1) and p38 mit

209 eal injury typically involves fibrosis, with transforming growth factor beta1 (TGF-beta1) as one of i

210 al immunosensor for the determination of the transforming growth factor beta1 (TGF-beta1) cytokine co

211 Increased transforming growth factor beta1 (TGF-beta1) in mammary

212 Transforming growth factor beta1 (TGF-beta1) is a master

213 KRAS-variant with p16 status and blood-based transforming growth factor beta1 (TGF-beta1).

214 Transforming growth factor beta1 (TGFbeta1) is the princ

215 that the integrin alphavbeta8 and its latent transforming growth factor beta1 (TGFbeta1) protein liga

216 High levels of transforming growth factor beta1 (TGFbeta1) were detecte

217 ide SLC4A2 expression under stimulation with transforming growth factor beta1 (TGFbeta1), a cytokine

218 gressive changes in renal mRNA expression of transforming growth factor beta1 (TGFbeta1), endothelin-

219 th factor receptor 1, 2, and 3; osteopontin; transforming growth factor beta1 and beta2; thrombospond

220 es the release of active MMP2 in response to transforming growth factor beta1 and rescues tissue inte

221 Mechanistically, this process engages the transforming growth factor beta1 protein and Notch signa

222 hemokine ligand 5 [CCL5]) and profibrogenic (transforming growth factor beta1, collagen type 4 alpha

223 o enhanced (by 20% to 40%) the expression of transforming growth factors beta1 and beta2, vascular en

224 e increase in collagen I and III expression, transforming growth factor-beta1 (TGF- beta1) expression

225 pression of Hmga2 enhances the activation of transforming growth factor-beta1 (TGF-beta1) and Cxcl12

226 interactions with soluble mediators such as transforming growth factor-beta1 (TGF-beta1) and mechani

227 Because the signaling of transforming growth factor-beta1 (TGF-beta1) and tumor n

228 Both a neutralizing anti-transforming growth factor-beta1 (TGF-beta1) antibody an

229 s inhibited by increased accumulation of the transforming growth factor-beta1 (TGF-beta1) in skeletal

230 Transforming growth factor-beta1 (TGF-beta1) may stimula

231 ibrogenic phenotype through the induction of transforming growth factor-beta1 (TGF-beta1), collagen d

232 pression variations (versus normal aorta) of transforming growth factor-beta1 (TGF-beta1), connective

233 e loss induced by AbetaOs, via production of transforming growth factor-beta1 (TGF-beta1).

234 (Mmp2) and Mmp9, which could activate latent transforming growth factor-beta1 (TGF-beta1).

235 onor corneas with interleukin-10 (IL-10) and transforming growth factor-beta1 (TGFbeta1) altered the

236 was up-regulated by the profibrotic cytokine transforming growth factor-beta1 and in PD effluent-deri

237 d investigated the interrelationship between transforming growth factor-beta1 and secreted frizzled-r

238 ponse to myelin perturbations, we identified transforming growth factor-beta1 as a partial mediator o

239 On the molecular level, microglial transforming growth factor-beta1 expression is down-regu

240 l population and increased the expression of transforming growth factor-beta1 in the liver.

241 The myokine transforming growth factor-beta1 increases during inflam

242 We observed that the transforming growth factor-beta1 inhibitor, secreted fri

243 We show that transforming growth factor-beta1 is responsible for the

244 ional repressors, snail and slug, induced by transforming growth factor-beta1 or extracellular matrix

245 In activation of the transforming growth factor-beta1 precursor (pro-TGF-beta

246 Gene set enrichment analysis uncovered transforming growth factor-beta1 signaling activation in

247 2 physically interacted and colocalized with transforming growth factor-beta1 through its cysteine-ri

248 TGF-beta1 (transforming growth factor-beta1) importantly contribute

249 Alu RNA expression is also induced by transforming growth factor-beta1, a major driver of EMT.

250 ession levels of fibroblast growth factor-2, transforming growth factor-beta1, and platelet-derived g

251 tu by antagonizing E-cadherin, combined with transforming growth factor-beta1, epidermal growth facto

252 ditioned medium resulted in up-regulation of transforming growth factor-beta1, transforming growth fa

253 ed mesenchymal cells secreted high levels of transforming growth factor-beta1, which down-regulates m

254 ecreted frizzled-related protein 2 prevented transforming growth factor-beta1-induced atrophy in C2C1

255 tablishes a positive feedback loop enhancing transforming growth factor-beta1-mediated atrophic effec

256 rizzled-related protein 2 reduction enhances transforming growth factor-beta1-mediated effects and in

257 beta6 integrin, an activator of latent local transforming growth factor-beta1.

258 Increased levels of active transforming growth factor-beta2 (TGF-beta2) in the aque

259 ulation of transforming growth factor-beta1, transforming growth factor-beta2, and collagens I and II

260 Transforming growth factor-betas regulate a wide range o

261 Here we show that transforming growth factor receptor 1 (TGFbetaR1) has an

262 es showed aberrant tumor necrosis factor and transforming growth factor signaling in metastatic cells

263 and associated with increased production of transforming growth factor (TGF) beta and interleukin (I

264 hymal self-organisation relies on restricted transforming growth factor (TGF) beta signalling, which

265 n cells were pretreated with blockers of the transforming growth factor (TGF) superfamily, purinergic

266 l-mesenchymal transition (EMT) is induced by transforming growth factor (TGF)-beta and facilitates tu

267 e further characterized by the activation of transforming growth factor (TGF)-beta and TGF-beta targe

268 Transforming growth factor (TGF)-beta cytokines signal v

269 n factor 15 (GDF15), a distant member of the transforming growth factor (TGF)-beta family, is a secre

270 expression in response to two members of the transforming growth factor (TGF)-beta family, TGF-beta1

271 The roles of transforming growth factor (TGF)-beta in extracellular m

272 In addition, culture in the presence of transforming growth factor (TGF)-beta inhibitors allows

273 promote SCC tumor initiation in concert with transforming growth factor (TGF)-beta present in the tum

274 Transforming growth factor (TGF)-beta signaling disorder

275 Herein, we analyzed the role of transforming growth factor (TGF)-beta signaling for CNV

276 the activity intrinsic to EMD that provokes transforming growth factor (TGF)-beta signaling in oral

277 The transforming growth factor (TGF)-beta signaling pathway

278 We provide evidence that Lfng regulates transforming growth factor (TGF)-beta signaling through

279 Genes whose products mediate transforming growth factor (TGF)-beta signaling were als

280 red as having tumour-suppressive properties, transforming growth factor (TGF)-beta signalling is alte

281 hological formation, neural development, and transforming growth factor (TGF)-beta signalling of the

282 Transforming growth factor (TGF)-beta supports multiple

283 C or TDFSM controls, was highly dependent on transforming growth factor (TGF)-beta, but not promoted

284 We tested whether transforming growth factor (TGF)-beta, which can functio

285 Antioxidant- and transforming growth factor (TGF)-beta-related genes were

286 -mesenchymal transition (EMT) in response to transforming growth factor (TGF)-beta.

287 kine that induces myofibroblast formation is transforming growth factor (TGF)-beta.

288 In this review, we concentrate on the transforming growth factor (TGF)-beta/bone morphogenetic

289 We now showed that transforming growth factor (TGF)-beta/Smad signaling par

290 Recent findings suggesting transforming growth factor (TGF)-beta1 activation by mec

291 uction of hepatocyte growth factor (HGF) and transforming growth factor (TGF)-beta1 caused by injury.

292 Transforming growth factor (TGF)-beta1 contributes to au

293 first documented protein known to stimulate transforming growth factor (TGF)-beta1 to -beta3 transla

294 ADAM10 expression is increased by transforming growth factor (TGF)-beta1, and ADAM10-media

295 on of pro-fibrotic growth factors, including transforming growth factor (TGF)-beta1, in human granulo

296 disruption of cell-cell contact can promote transforming growth factor (TGF)-beta1-induced EMT and t

297 trate the potential of this platform for: i) transforming growth factor (TGF)-beta1-induced spatial d

298 JAK-STAT3 axis, Wnt-GSK3 signalling, and the transforming growth factor (TGF)beta family.

299 tokines (tumour necrosis factor [TNF]-alpha, transforming growth factor [TGF]-beta1, interleukin [IL]

300 e cells (SMCs) were stimulated with elevated transforming growth factor (TGFbeta) and its signaling p